A generic alternative indicated for women's health and oncology support. Targeted mechanisms provide essential hormonal modulation to assist in maintaining long-term wellness outcomes.
An aromatase inhibitor developed to manage breast cancer in postmenopausal women and intended to alleviate tumor growth by targeting estrogen synthesis.
Mechanism of Action
It inhibits the aromatase enzyme, which converts androgens into estrogens in peripheral tissues. Lowering estrogen levels stops the growth of hormone-dependent cancer cells.
Route of Administration
Oral
Onset Time
Several days
Duration
24 hours
Contraindications
Premenopausal status, Pregnancy, Severe kidney disease
Severe Adverse Events
Osteoporosis (bone loss), Bone fractures, Severe skin reactions, Heart disease
Information for Anastrozole is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
